Leverage remains moderate with D/E at 0.68 and total debt of $1.1B, while retained earnings surged to $7.0B from $4.7B in 2024Q1, indicating robust internal capital generation.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 1.51B | 1.34B | 1.4B | 1.5B | 1.1B | 955.65M | 1.06B | 679.64M | 654.17M | 971.99M | 845.58M | 821.63M | 759.4M | 652.71M | 569.54M | 524.23M | 460.59M | 376.34M | 355.89M | 305.66M | 302.26M | 299.25M | 301.59M | 370.59M | 289.12M | 235.58M | 215.83M | 232.4M | 263.3M | 274.2M | 301.7M |
| Cash & Short-Term Investments | 196.93M | 180.07M | 288.27M | 453.93M | 112.55M | 144.45M | 383.93M | 90.33M | 123.79M | 471.93M | 391.85M | 342.58M | 322.54M | 279.06M | 223.99M | 183.9M | 156.91M | 106.73M | 78.87M | 60.36M | 96.67M | 132.73M | 137.27M | 220.71M | 147.19M | 79.56M | 75.2M | 58.6M | 109.1M | 107M | 127.7M |
| Cash Only | 196.93M | 180.07M | 288.27M | 453.93M | 112.55M | 144.45M | 383.93M | 90.33M | 123.79M | 187.68M | 154.9M | 128.99M | 322.54M | 279.06M | 223.99M | 183.9M | 156.91M | 106.73M | 78.87M | 60.36M | 61.67M | 67.15M | 47.16M | 186.72M | 113.79M | 66.67M | 46.01M | 58.6M | 109.1M | 107M | 127.7M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 284.25M | 236.95M | 213.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35M | 65.58M | 90.12M | 33.99M | 33.4M | 12.89M | 29.2M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 741.67M | 693.19M | 561.32M | 529.53M | 490.9M | 425.58M | 374.74M | 307.49M | 258.52M | 270.07M | 232.17M | 200.11M | 181.31M | 158.04M | 138.32M | 141.28M | 120.08M | 115.11M | 111.5M | 108.38M | 81.39M | 71.69M | 0 | 53.98M | 45.69M | 50.77M | 57.27M | 58.35M | 47.9M | 47.3M | 66.6M |
| Days Sales Outstanding | 57.06 | 58.79 | 52.57 | 52.79 | 53.21 | 48.31 | 50.53 | 46.63 | 42.63 | 50.06 | 47.73 | 45.6 | 44.54 | 41.89 | 39.04 | 42.31 | 39.72 | 40.73 | 39.74 | 42.88 | 40.19 | 41.01 | - | 41.39 | 40.41 | 48 | 56.89 | 59.79 | 54.65 | 65.64 | 90.81 |
| Inventory | 391.58M | 377.76M | 381.88M | 380.28M | 367.82M | 269.03M | 209.87M | 195.02M | 173.3M | 164.32M | 158.03M | 188.83M | 160.34M | 133.43M | 140.95M | 133.1M | 127.89M | 110.42M | 115.93M | 98.8M | 96M | 69.37M | 76.42M | 75.33M | 75.09M | 86.19M | 65.94M | 47.5M | 55.4M | 60.2M | 48.4M |
| Days Inventory Outstanding | 82.36 | 83.86 | 91.79 | 94.36 | 98.5 | 74.06 | 67.46 | 68.35 | 65.1 | 68.81 | 72.1 | 96.85 | 87.39 | 78.43 | 86.58 | 84.9 | 88.95 | 79.76 | 85.61 | 78.56 | 97.44 | 80.33 | 103.25 | 111.92 | 124.61 | 155.17 | 140.92 | 105.14 | 142.2 | 183.41 | 171.68 |
| Other Current Assets | 117.35M | 31.35M | 109.81M | 83.14M | 88.46M | 74.59M | 59.64M | 54.81M | 54.14M | 101.14M | 91.21M | 101.9M | 124.14M | 82.18M | 66.28M | 65.96M | 55.71M | 44.08M | 49.6M | 38.12M | 28.21M | 25.46M | 22.26M | 20.57M | 134.94M | 19.05M | 17.43M | 67.9M | 50.9M | 59.7M | 59M |
| Total Non-Current Assets | 1.93B | 2.01B | 1.89B | 1.76B | 1.65B | 1.48B | 1.23B | 1.15B | 883.18M | 741.43M | 685.12M | 653.36M | 624.81M | 577.81M | 534.07M | 506.59M | 436.55M | 432.19M | 409.55M | 396.52M | 257.3M | 191.43M | 212.65M | 151.29M | 127.53M | 137.53M | 119.97M | 127.8M | 127.2M | 102.8M | 72.2M |
| Property, Plant & Equipment | 856M | 870.61M | 829.25M | 817.68M | 768.09M | 692.77M | 646.34M | 614.45M | 437.27M | 379.1M | 357.42M | 333.03M | 303.59M | 281.21M | 245.18M | 216.78M | 201.72M | 199.95M | 189.65M | 141.85M | 99.63M | 65.7M | 62.63M | 45.22M | 49.45M | 49.22M | 45.66M | 39.55M | 41.5M | 41M | 36.4M |
| Fixed Asset Turnover | 5.27x | 4.94x | 4.70x | 4.48x | 4.38x | 4.64x | 4.19x | 3.92x | 5.06x | 5.19x | 4.97x | 4.81x | 4.89x | 4.90x | 5.28x | 5.62x | 5.47x | 5.16x | 5.40x | 6.50x | 7.42x | 9.71x | 8.77x | 10.53x | 8.34x | 7.84x | 8.05x | 9.01x | 7.71x | 6.41x | 7.35x |
| Goodwill | 410.95M | 414M | 405.1M | 365.96M | 361.8M | 359.35M | 243.35M | 239.72M | 214.49M | 199.87M | 178.23M | 178.93M | 184.45M | 180.52M | 174.99M | 172.61M | 149.11M | 148.71M | 138.77M | 236.41M | 104.83M | 88.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 98.17M | 109.84M | 111.68M | 84.5M | 97.67M | 99.03M | 52.54M | 58.47M | 41.83M | 43.85M | 46.16M | 55.91M | 65.12M | 58.84M | 62.83M | 69.21M | 55.75M | 63.91M | 68.33M | 0 | 43.35M | 30.62M | 124.49M | 61.77M | 56.16M | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 681.26M | 297.09M | 57.72M | 56.19M | 55.5M | 18.6M | 12.06M | 13.66M | 10.89M | 9.95M | 10.98M | 12.16M | 10.77M | 13.07M | 10.32M | 12.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 491.12M | 291.08M | 364.17M | 332.98M | 307.01M | 287.02M | 245.98M | 218.44M | 170.22M | 100.97M | 86.63M | 73.33M | 60.89M | 44.16M | 40.74M | 35.9M | 29.33M | 18.61M | 11.64M | 11.61M | 6.24M | 6.57M | 25.52M | 44.3M | 23.8M | 88.32M | 74.31M | 86.02M | 81.7M | 61.8M | 35.8M |
| Total Assets | 3.44B | 3.35B | 3.29B | 3.26B | 2.75B | 2.44B | 2.29B | 1.83B | 1.54B | 1.71B | 1.53B | 1.47B | 1.38B | 1.23B | 1.1B | 1.03B | 897.14M | 808.53M | 765.44M | 702.18M | 559.56M | 490.68M | 514.24M | 521.88M | 416.65M | 373.11M | 335.8M | 360.2M | 390.5M | 377M | 373.9M |
| Asset Turnover | 1.34x | 1.28x | 1.18x | 1.12x | 1.23x | 1.32x | 1.18x | 1.31x | 1.44x | 1.15x | 1.16x | 1.09x | 1.07x | 1.12x | 1.17x | 1.18x | 1.23x | 1.28x | 1.34x | 1.31x | 1.32x | 1.30x | 1.07x | 0.91x | 0.99x | 1.03x | 1.09x | 0.99x | 0.82x | 0.70x | 0.72x |
| Asset Growth % | 11.51% | 1.74% | 1.03% | 18.68% | 12.7% | 6.22% | 25.22% | 19.2% | -10.28% | 11.94% | 3.78% | 6.56% | 12.49% | 11.5% | 7.06% | 14.9% | 10.96% | 5.63% | 9.01% | 25.49% | 14.04% | -4.58% | -1.46% | 25.25% | 11.67% | 11.11% | -6.78% | -7.76% | 3.58% | 0.83% | 19.65% |
| Total Current Liabilities | 1.29B | 1.15B | 1.07B | 951.55M | 1.24B | 763.58M | 582.76M | 725.34M | 770.44M | 1B | 934.57M | 856.76M | 820.91M | 478.35M | 406.33M | 436.88M | 285.11M | 256.31M | 295.29M | 223.39M | 124.74M | 106.57M | 99.95M | 100.74M | 75.68M | 71.38M | 74.05M | 75.5M | 78.5M | 74.3M | 51.1M |
| Accounts Payable | 129.1M | 110.41M | 114.21M | 110.64M | 110.22M | 116.14M | 74.56M | 72.17M | 69.53M | 66.97M | 60.06M | 52.65M | 44.74M | 29.94M | 35.29M | 36.55M | 22.67M | 19.13M | 28.01M | 32.51M | 24.37M | 19.84M | 14.72M | 19.16M | 9.43M | 10.89M | 13.71M | 21.82M | 26.8M | 12.5M | 18.7M |
| Days Payables Outstanding | 26.24 | 24.51 | 27.45 | 27.45 | 29.52 | 31.97 | 23.96 | 25.3 | 26.12 | 28.04 | 27.4 | 27 | 24.39 | 17.6 | 21.68 | 23.32 | 15.77 | 13.82 | 20.68 | 25.85 | 24.74 | 22.98 | 19.89 | 28.46 | 15.64 | 19.6 | 29.31 | 48.3 | 68.79 | 38.08 | 66.33 |
| Short-Term Debt | 669M | 500.07M | 417.79M | 325M | 653.98M | 148.5M | 49.99M | 288.76M | 398.94M | 655M | 611M | 573M | 549M | 278.04M | 213.11M | 243.92M | 129.86M | 119.6M | 151.38M | 72.96M | 678K | 551K | 1.29M | 494K | 973K | 8.38M | 8.47M | 3.54M | 5.2M | 4.1M | 3M |
| Deferred Revenue (Current) | 143.69M | 35.26M | 33.8M | 37.2M | 37.94M | 40.03M | 42.57M | 41.46M | 41.29M | 29.18M | 27.38M | 25.58M | 31.81M | 21.46M | 20.19M | 15.03M | 13.98M | 12.61M | 11.29M | 10.68M | 8.98M | 7.96M | 10.15M | 8.28M | 13.57M | 13.22M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 158.13M | 201.96M | 174.58M | 174.38M | 142.99M | 182.93M | 167.65M | 127.17M | 109.49M | 102.94M | 91.11M | 77.03M | 75.23M | 62.47M | 53.41M | 51.37M | 0 | 0 | 0 | 0 | 1.78M | 2.19M | 2.79M | 2.25M | 0 | 0 | 51.86M | 48.28M | 42.5M | 57.7M | 29.4M |
| Current Ratio | 1.17x | 1.17x | 1.31x | 1.57x | 0.89x | 1.25x | 1.82x | 0.94x | 0.85x | 0.97x | 0.90x | 0.96x | 0.93x | 1.36x | 1.40x | 1.20x | 1.62x | 1.47x | 1.21x | 1.37x | 2.42x | 2.81x | 3.02x | 3.68x | 3.82x | 3.30x | 2.91x | 3.08x | 3.35x | 3.69x | 5.90x |
| Quick Ratio | 0.87x | 0.84x | 0.95x | 1.17x | 0.59x | 0.90x | 1.46x | 0.67x | 0.62x | 0.80x | 0.74x | 0.74x | 0.73x | 1.09x | 1.05x | 0.90x | 1.17x | 1.04x | 0.81x | 0.93x | 1.65x | 2.16x | 2.25x | 2.93x | 2.83x | 2.09x | 2.02x | 2.45x | 2.65x | 2.88x | 4.96x |
| Cash Conversion Cycle | 113.17 | 118.14 | 116.9 | 119.7 | 122.2 | 90.4 | 94.03 | 89.69 | 81.61 | 90.83 | 92.43 | 115.45 | 107.54 | 102.72 | 103.94 | 103.9 | 112.9 | 106.66 | 104.67 | 95.59 | 112.89 | 98.36 | - | 124.84 | 149.37 | 183.57 | 168.5 | 116.64 | 128.06 | 210.97 | 196.16 |
| Total Non-Current Liabilities | 542.1M | 596.56M | 630.21M | 823.85M | 902.23M | 983.63M | 1.08B | 929.31M | 776.14M | 762.69M | 704.35M | 702.23M | 445.72M | 233.95M | 61.01M | 54.34M | 37.75M | 37.64M | 31.95M | 40.46M | 24.96M | 14.8M | 16.63M | 7.85M | 6.2M | 0 | 0 | 400K | 4.2M | 1.4M | 100K |
| Long-Term Debt | 299.87M | 475.99M | 449.79M | 622.88M | 694.39M | 775.21M | 858.49M | 698.91M | 601.35M | 606.08M | 593.11M | 597.09M | 350M | 150.36M | 1.39M | 2.5M | 3.42M | 4.28M | 5.09M | 5.73M | 6.45M | 0 | 519K | 786K | 0 | 0 | 0 | 300K | 4.2M | 0 | 0 |
| Capital Lease Obligations | 406.89M | 101.15M | 97.84M | 99.67M | 101.24M | 87.38M | 77.04M | 67.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 132.82M | 31.86M | 11.31M | 7.24M | 8.15M | 8.94M | 11.71M | 33.02M | 29.27M | 25.35M | 39.29M | 49.39M | 41.69M | 33.95M | 23.03M | 23.29M | 18.66M | 18.28M | 11.93M | 14.7M | 7.15M | 6.03M | 8.45M | 236K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 56.5M | -44.62M | 44.34M | 65.53M | 67.59M | 70.94M | 85.6M | 81.16M | 84.83M | 95.72M | 38.94M | 28.7M | 32.36M | 31.21M | 23.9M | 17.73M | 11.04M | 11.27M | 11.14M | 13.83M | 4.52M | 968K | 1.01M | 1.05M | 0 | 0 | 0 | -259K | 0 | 0 | 100K |
| Total Liabilities | 1.83B | 1.75B | 1.7B | 1.78B | 2.14B | 1.75B | 1.66B | 1.65B | 1.55B | 1.77B | 1.64B | 1.56B | 1.27B | 712.3M | 467.35M | 491.22M | 322.86M | 293.95M | 327.24M | 263.86M | 149.7M | 121.37M | 116.58M | 108.58M | 75.68M | 71.38M | 74.05M | 75.9M | 82.7M | 74.3M | 51.2M |
| Total Debt | 1.1B | 1.08B | 986.95M | 1.07B | 1.47B | 1.03B | 1B | 1.07B | 1B | 1.26B | 1.2B | 1.17B | 899M | 428.39M | 214.5M | 246.42M | 133.28M | 123.88M | 156.48M | 78.68M | 7.13M | 551K | 1.81M | 1.28M | 1.02M | 8.38M | 8.47M | 3.84M | 9.4M | 4.1M | 3M |
| Net Debt | 899.15M | 897.14M | 698.68M | 613.42M | 1.36B | 886.55M | 619.32M | 980.1M | 876.49M | 1.07B | 1.05B | 1.04B | 576.46M | 149.34M | -9.48M | 62.52M | -23.64M | 17.16M | 77.61M | 18.32M | -54.54M | -66.6M | -45.35M | -95.66M | -112.77M | -58.29M | -37.53M | -54.73M | -99.7M | -102.9M | -124.7M |
| Debt / Equity | 0.68x | 0.67x | 0.62x | 0.72x | 2.41x | 1.49x | 1.59x | 6.02x | - | - | - | - | 7.65x | 0.83x | 0.34x | 0.46x | 0.23x | 0.24x | 0.36x | 0.18x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.03x | 0.03x | 0.01x | 0.03x | 0.01x | 0.01x |
| Debt / EBITDA | 0.68x | 0.73x | 0.78x | 0.88x | 1.45x | 0.99x | 1.27x | 1.67x | 1.74x | 2.54x | 2.81x | 3.17x | 2.82x | 1.33x | 0.68x | 0.87x | 0.53x | 0.55x | 0.71x | 0.44x | 0.05x | 0.00x | 0.01x | 0.01x | 0.01x | 0.11x | 0.12x | 0.06x | 0.21x | 0.41x | 0.05x |
| Net Debt / EBITDA | 0.56x | 0.61x | 0.56x | 0.51x | 1.34x | 0.86x | 0.78x | 1.53x | 1.53x | 2.16x | 2.45x | 2.82x | 1.81x | 0.46x | -0.03x | 0.22x | -0.09x | 0.08x | 0.35x | 0.10x | -0.35x | -0.48x | -0.36x | -0.96x | -1.31x | -0.74x | -0.52x | -0.86x | -2.22x | -10.29x | -2.17x |
| Interest Coverage | 37.44x | 35.61x | 36.57x | 26.52x | 22.58x | 31.28x | 20.98x | 17.82x | 14.17x | 11.24x | 11.04x | 10.34x | 16.98x | 49.88x | 68.73x | 131.99x | 116.75x | 123.40x | 38.09x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.61B | 1.61B | 1.6B | 1.48B | 608.74M | 689.99M | 632.79M | 177.82M | -9.23M | -53.84M | -108.21M | -84M | 117.59M | 518.21M | 636.26M | 539.59M | 574.28M | 514.58M | 438.19M | 438.32M | 409.86M | 369.31M | 397.66M | 413.29M | 340.97M | 301.73M | 261.75M | 284.3M | 307.8M | 302.7M | 322.7M |
| Equity Growth % | 15.12% | 0.63% | 7.46% | 143.87% | -11.78% | 9.04% | 255.85% | 2025.97% | 82.85% | 50.24% | -28.83% | -171.43% | -77.31% | -18.55% | 17.91% | -6.04% | 11.6% | 17.43% | -0.03% | 6.94% | 10.98% | -7.13% | -3.78% | 21.21% | 13.01% | 15.28% | -7.93% | -7.63% | 1.68% | -6.2% | 15.62% |
| Book Value per Share | 19.99 | 19.90 | 19.16 | 17.68 | 7.20 | 7.97 | 7.30 | 2.03 | -0.10 | -0.60 | -1.19 | -0.90 | 1.16 | 4.80 | 5.67 | 4.63 | 4.82 | 4.24 | 3.52 | 3.40 | 3.11 | 2.71 | 2.78 | 2.88 | 2.43 | 2.18 | 1.81 | 1.79 | 2.03 | 2.01 | 2.05 |
| Total Shareholders' Equity | 1.61B | 1.61B | 1.6B | 1.48B | 608.74M | 689.99M | 632.09M | 177.47M | -9.51M | -54.11M | -108.35M | -84.13M | 117.52M | 518.19M | 636.22M | 539.58M | 574.24M | 514.57M | 438.19M | 438.32M | 409.86M | 369.01M | 397.66M | 413.29M | 340.97M | 301.73M | 261.75M | 284.3M | 307.8M | 302.7M | 322.7M |
| Common Stock | 10.87M | 10.84M | 10.78M | 10.75M | 10.72M | 10.69M | 10.65M | 10.57M | 10.51M | 10.43M | 10.33M | 10.26M | 10.2M | 10.12M | 10.02M | 9.92M | 9.8M | 9.63M | 9.54M | 9.45M | 4.66M | 4.59M | 4.52M | 4.44M | 4.23M | 4.13M | 4.03M | 4M | 0 | 0 | 0 |
| Retained Earnings | 7.01B | 6.39B | 5.33B | 4.44B | 3.6B | 2.92B | 2.18B | 1.6B | 1.17B | 803.54M | 540.4M | 318.36M | 1.68B | 1.49B | 1.31B | 1.13B | 965.54M | 824.26M | 702.03M | 585.86M | 490.61M | 396.94M | 318.68M | 240.35M | 183.26M | 137.87M | 100.25M | 63.6M | 31M | 46.3M | 67.4M |
| Treasury Stock | -7.26B | -6.56B | -5.33B | -4.47B | -4.39B | -3.57B | -2.8B | -2.6B | -2.29B | -1.91B | -1.63B | -1.32B | -2.45B | -1.83B | -1.46B | -1.32B | -1.06B | -914.76M | -830.39M | -696.67M | -577.83M | -472.1M | -348.33M | -219.45M | -178.36M | -147.47M | -134.48M | -64.2M | 0 | 0 | 0 |
| Accumulated OCI | -63.54M | -68.84M | -93.64M | -71.21M | -77.8M | -53.48M | -53.62M | -46.18M | -41.79M | -36.47M | -43.05M | -42.27M | -8.07M | 13.62M | 15.95M | 15.44M | 13.47M | 10.34M | 5.67M | 24.91M | 12.42M | 2.18M | 11.97M | 4.7M | -2.51M | -6.69M | -4.96M | -3.5M | -41M | -30.4M | -22.9M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 707K | 352K | 280K | 264K | 139K | 130K | 73K | 28K | 34K | 14K | 46K | 10K | 0 | 0 | 0 | 300K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Corporate consolidation pricing pressure
IDEXX's total assets have held steady near $3.4B while equity grew to $1.6B by 2026Q2, per reported figures, indicating a stable yet improving capital base.
The balance sheet appears to be strengthening as retained earnings climbed from $4.7B in 2024Q1 to $7.0B in 2026Q2, reflecting robust profitability. Total liabilities have remained roughly flat around $1.8B, suggesting that asset growth is being funded internally rather than through additional debt. This trend implies a self-sustaining business model with improving financial flexibility.
Total debt has hovered near $1.1B over the past year, with D/E fluctuating between 0.62 and 0.85, as per quarterly data, indicating manageable leverage.
The debt-to-equity ratio peaked at 0.85 in 2025Q2 but has since declined to 0.68 in 2026Q2, suggesting a slight deleveraging trend. Debt levels appear stable and are likely strategic, supporting growth initiatives rather than covering operational shortfalls. Given the company's strong cash flow generation, refinancing risk appears low, but investors should monitor any future increases in leverage.
PP&E net of $856M represents about 25% of total assets, while goodwill of $411M is stable, per reported figures, indicating a balanced asset base.
The relatively low PP&E intensity suggests an asset-light model, consistent with a diagnostics company that relies on consumables and services rather than heavy manufacturing. Goodwill has remained stable around $410M, implying no major acquisitions or impairment concerns. The asset mix supports high returns on invested capital, as the business generates significant revenue from a modest fixed asset base.
Retained earnings surged to $7.0B in 2026Q2 from $4.7B in 2024Q1, per financial statements, while equity grew to $1.6B, indicating strong internal capital generation.
The growth in retained earnings far outpaces the increase in total equity, which suggests that share repurchases are offsetting some of the earnings retention. Despite aggressive buybacks, equity has remained stable, indicating that the company is returning capital to shareholders while still building its equity base. This balance between reinvestment and shareholder returns appears sustainable.
Current ratio improved to 1.17 in 2026Q2 from 1.11 a year earlier, but cash fell to $196.9M from $401.6M in 2024Q2, per reported data.
The current ratio remains above 1.0, indicating sufficient short-term assets to cover liabilities, but the cash balance has declined significantly over the past two years. This decline is likely due to share repurchases and debt repayments, as operating cash flow remains robust. The liquidity position appears adequate for near-term obligations, but the shrinking cash buffer warrants monitoring if cash generation slows.
The shift toward large corporate veterinary groups could erode pricing power, as suggested by the company's reliance on fragmented independent clinics.
While IDEXX's balance sheet appears healthy, the growing consolidation of veterinary practices into large corporate entities may pose a long-term threat. These large buyers could demand volume discounts, pressuring margins and potentially affecting the stability of deferred revenue and cash flows. This risk is not immediately visible in the balance sheet but could impact future asset quality and profitability.
Quick answers to the most common questions about buying IDXX stock.
As of 2025, IDEXX Laboratories, Inc. (IDXX) had total assets of $3.35B including $1.34B in current assets.
IDEXX Laboratories, Inc. (IDXX) carries total debt of $1.08B, offset by $180.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
IDEXX Laboratories, Inc. (IDXX) has total shareholders' equity (book value) of $1.61B ($19.90 book value per share). Book value represents the net worth of the company belonging to common stock holders.
IDEXX Laboratories, Inc. (IDXX) reported a current ratio of 1.17x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.